Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 17 (14) , 2171-2179
Abstract
Background: Increased expressions of CD16 on classical monocytes precede their transition to intermediate monocytes. Thus far, the influence of lipids on the expression of CD14 and CD16 on monocyte subsets in coronary atherosclerosis (CA) remains unclear. The aim of this study was to investigate the underlying association between blood lipids and the expression of CD14 and CD16 on monocyte subsets.Keywords
This publication has 29 references indexed in Scilit:
- Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysisAtherosclerosis, 2014
- Increased proatherogenic monocyte–platelet cross‐talk in monocyte subpopulations of patients with stable coronary artery diseaseJournal of Internal Medicine, 2013
- Monocytes in Coronary Artery Disease and AtherosclerosisJACC, 2013
- Monocyte heterogeneity in human cardiovascular diseaseImmunobiology, 2012
- CD14++CD16+ Monocytes Independently Predict Cardiovascular EventsJACC, 2012
- Monocyte subpopulations and cardiovascular risk in chronic kidney diseaseNature Reviews Nephrology, 2012
- ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in miceJournal of Clinical Investigation, 2011
- Inhibition of arterial lesion progression in CD16-deficient mice: evidence for altered immunity and the role of IL-10Cardiovascular Research, 2009
- Peripheral Blood Mononuclear Phagocyte Subpopulations as Cellular Markers in HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- IL-4 Decreases the Expression of the Monocyte Differentiation Marker CD14, Paralleled by an Increasing Accessory PotencyImmunobiology, 1991